Envista Holdings (NVST) Stock Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

NVST Analyst Ratings

Moderate Buy

7 Buy

8 Hold

0 Sell

Based on 15 analysts giving stock ratings to

Envista

Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

NVST Stock 12 Month Forecast

Average Price Target

$552.04

▲(49.20% Upside)

Based on 15 Wall Street analysts offering 12 month price targets for Envista Holdings in the last 3 months. The average price target is $552.04 with a high forecast of $638.75 and a low forecast of $432.10. The average price target represents a 49.20% change from the last price of $370.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"357":"$357","498":"$498","639":"$639","427.5":"$427.5","568.5":"$568.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":638.74955372,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$638.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":552.0414695046155,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$552.04</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":432.09528634,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$432.10</span>\n  </div></div>","useHTML":true}}],"tickPositions":[357,427.5,498,568.5,639],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,365,386.0576579784615,407.1153159569231,428.1729739353846,449.23063191384614,470.2882898923077,491.34594787076924,512.4036058492308,533.4612638276923,554.5189218061539,575.5765797846154,596.634237763077,617.6918957415385,{"y":638.74955372,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,365,379.3878053465089,393.77561069301777,408.1634160395267,422.55122138603554,436.93902673254445,451.3268320790533,465.7146374255622,480.1024427720711,494.49024811858,508.8780534650889,523.2658588115978,537.6536641581066,{"y":552.0414695046155,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,365,370.1611758723077,375.3223517446154,380.4835276169231,385.6447034892308,390.8058793615385,395.96705523384617,401.12823110615386,406.2894069784615,411.4505828507692,416.6117587230769,421.7729345953846,426.9341104676923,{"y":432.09528634,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":358,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":370,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":370,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":371,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":371,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":371,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":371,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":371,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":371,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":371,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":371,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":370,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":365,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$638.75

Average Price Target$552.04

Lowest Price Target$432.10

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jeff Johnson

Robert W. Baird

$638.75→$488.46

Hold

32.02%

Upside

Downgraded

10/15/26

Envista downgraded to Neutral from Outperform at BairdEnvista downgraded to Neutral from Outperform at Baird

Michael Cherny

Leerink Partners

$657.54→$601.18

Buy

62.48%

Upside

Reiterated

10/14/26

Envista price target lowered to $32 from $35 at LeerinkEnvista price target lowered to $32 from $35 at Leerink

Jason Bednar

Piper Sandler

$526.03→$488.46

Hold

32.02%

Upside

Reiterated

10/09/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NYSE: NVST), Bristol-Myers Squibb (NYSE: BMY) and Eli Lilly & Co (NYSE: LLY)

Allen Lutz

Bank of America Securities

$638.75

Buy

72.64%

Upside

Reiterated

10/07/26

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NYSE: NVST) and Stryker (NYSE: SYK)

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

10/02/26

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NYSE: NVST) and Legend Biotech (NASDAQ: LEGN)

Vik Chopra

BMO Capital

$544.82→$488.46

Hold

32.02%

Upside

Reiterated

09/28/26

Envista price target lowered to $26 from $29 at BMO CapitalEnvista price target lowered to $26 from $29 at BMO Capital

David Saxon

Needham

―

Hold

―

Reiterated

09/24/26

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NYSE: NVST) and Arrowhead Pharmaceuticals (NASDAQ: ARWR)

Erin Wright

Morgan Stanley

$432.1

Hold

16.78%

Upside

Reiterated

09/18/26

Analysts Offer Insights on Healthcare Companies: Merck & Company (NYSE: MRK), Envista Holdings (NYSE: NVST) and Ultragenyx Pharmaceutical (NASDAQ: RARE)

Kevin Caliendo

UBS

$563.6→$507.24

Hold

37.09%

Upside

Reiterated

09/18/26

Envista Holdings (NVST) Receives a Hold from UBS

Jonathan Block

Stifel Nicolaus

$582.39

Buy

57.40%

Upside

Reiterated

09/18/26

Analysts Offer Insights on Healthcare Companies: Xenon (NASDAQ: XENE) and Envista Holdings (NYSE: NVST)

Lilia-Celine (Lily) Lozada

J.P. Morgan

$601.18

Buy

62.48%

Upside

Upgraded

09/03/26

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NYSE: NVST) and Alumis Inc. (NASDAQ: ALMS)

Glen Santangelo

Barclays

$601.18

Buy

62.48%

Upside

Reiterated

08/17/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NYSE: NVST), Healthequity (NASDAQ: HQY) and Insight Molecular Diagnostics (NASDAQ: IMDX)

Daniel Grosslight

Citi

$601.18

Hold

62.48%

Upside

Reiterated

08/10/26

Envista Holdings (NVST) Gets a Hold from Citi

Elizabeth Anderson CFA

Evercore ISI

$601.18

Buy

62.48%

Upside

Reiterated

08/06/26

Evercore ISI Sticks to Its Buy Rating for Envista Holdings (NVST)

Steven Valiquette

Mizuho Securities

$507.24→$544.82

Hold

47.25%

Upside

Reiterated

08/06/26

Envista price target raised to $29 from $27 at MizuhoEnvista price target raised to $29 from $27 at Mizuho

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jeff Johnson

Robert W. Baird

$638.75→$488.46

Hold

32.02%

Upside

Downgraded

10/15/26

Envista downgraded to Neutral from Outperform at BairdEnvista downgraded to Neutral from Outperform at Baird

Michael Cherny

Leerink Partners

$657.54→$601.18

Buy

62.48%

Upside

Reiterated

10/14/26

Envista price target lowered to $32 from $35 at LeerinkEnvista price target lowered to $32 from $35 at Leerink

Jason Bednar

Piper Sandler

$526.03→$488.46

Hold

32.02%

Upside

Reiterated

10/09/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NYSE: NVST), Bristol-Myers Squibb (NYSE: BMY) and Eli Lilly & Co (NYSE: LLY)

Allen Lutz

Bank of America Securities

$638.75

Buy

72.64%

Upside

Reiterated

10/07/26

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NYSE: NVST) and Stryker (NYSE: SYK)

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

10/02/26

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NYSE: NVST) and Legend Biotech (NASDAQ: LEGN)

Vik Chopra

BMO Capital

$544.82→$488.46

Hold

32.02%

Upside

Reiterated

09/28/26

Envista price target lowered to $26 from $29 at BMO CapitalEnvista price target lowered to $26 from $29 at BMO Capital

David Saxon

Needham

―

Hold

―

Reiterated

09/24/26

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NYSE: NVST) and Arrowhead Pharmaceuticals (NASDAQ: ARWR)

Erin Wright

Morgan Stanley

$432.1

Hold

16.78%

Upside

Reiterated

09/18/26

Analysts Offer Insights on Healthcare Companies: Merck & Company (NYSE: MRK), Envista Holdings (NYSE: NVST) and Ultragenyx Pharmaceutical (NASDAQ: RARE)

Kevin Caliendo

UBS

$563.6→$507.24

Hold

37.09%

Upside

Reiterated

09/18/26

Envista Holdings (NVST) Receives a Hold from UBS

Jonathan Block

Stifel Nicolaus

$582.39

Buy

57.40%

Upside

Reiterated

09/18/26

Analysts Offer Insights on Healthcare Companies: Xenon (NASDAQ: XENE) and Envista Holdings (NYSE: NVST)

Lilia-Celine (Lily) Lozada

J.P. Morgan

$601.18

Buy

62.48%

Upside

Upgraded

09/03/26

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NYSE: NVST) and Alumis Inc. (NASDAQ: ALMS)

Glen Santangelo

Barclays

$601.18

Buy

62.48%

Upside

Reiterated

08/17/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NYSE: NVST), Healthequity (NASDAQ: HQY) and Insight Molecular Diagnostics (NASDAQ: IMDX)

Daniel Grosslight

Citi

$601.18

Hold

62.48%

Upside

Reiterated

08/10/26

Envista Holdings (NVST) Gets a Hold from Citi

Elizabeth Anderson CFA

Evercore ISI

$601.18

Buy

62.48%

Upside

Reiterated

08/06/26

Evercore ISI Sticks to Its Buy Rating for Envista Holdings (NVST)

Steven Valiquette

Mizuho Securities

$507.24→$544.82

Hold

47.25%

Upside

Reiterated

08/06/26

Envista price target raised to $29 from $27 at MizuhoEnvista price target raised to $29 from $27 at Mizuho

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AORTArtivion

MDWDMediwound

IMUXImmunic

RZLTRezolute

DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Envista Holdings

3 Months

Allen LutzBank of America Securities

Success Rate

11/19 ratings generated profit

Average Return

+2.22%

Copying Allen Lutz's trades and holding each position for 3 Months would result in 57.89% of your transactions generating a profit, with an average return of +2.22% per trade.

1 Year

Allen LutzBank of America Securities

Success Rate

12/19 ratings generated profit

Average Return

+15.15%

Copying Allen Lutz's trades and holding each position for 1 Year would result in 63.16% of your transactions generating a profit, with an average return of +15.15% per trade.

2 Years

Allen LutzBank of America Securities

Success Rate

14/19 ratings generated profit

Average Return

+21.24%

Copying Allen Lutz's trades and holding each position for 2 Years would result in 73.68% of your transactions generating a profit, with an average return of +21.24% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NVST Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, NVST has received 17 Buy Ratings, 17 Hold Ratings, and 0 Sell Ratings. NVST average Analyst price target in the past 3 months is 552.04.

Each month's total comprises the sum of three months' worth of ratings.

NVST Financial Forecast

NVST Earnings Forecast

Next quarter’s earnings estimate for NVST is $6.69 with a range of $6.35 to $7.14. The previous quarter’s EPS was $7.70. NVST beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year NVST has Performed in-line its overall industry.

NVST Sales Forecast

Next quarter’s sales forecast for NVST is $12.94B with a range of $12.85B to $13.17B. The previous quarter’s sales results were $13.72B. NVST beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year NVST has Performed in-line its overall industry.

NVST Stock Forecast FAQ

What is MX:NVST’s average 12-month price target, according to analysts?

Based on analyst ratings, Envista Holdings Corp’s 12-month average price target is 552.04.

What is MX:NVST’s upside potential, based on the analysts’ average price target?

Envista Holdings Corp has 49.20% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Envista Holdings Corp a Buy, Sell or Hold?

Envista Holdings Corp has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 8 hold ratings and 0 sell ratings.

What is Envista Holdings Corp’s share price target?

The average share price target for Envista Holdings Corp is 552.04. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $638.75 ,and the lowest forecast is $432.10. The average share price target represents 49.20% Increase from the current price of $370.

What do analysts say about Envista Holdings Corp?

Envista Holdings Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of Envista Holdings Corp?

To buy shares of MX:NVST, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Envista Holdings (NVST) Stock Forecast & Price Target

NVST Analyst Ratings

NVST Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Envista Holdings

NVST Analyst Recommendation Trends

NVST Financial Forecast

NVST Earnings Forecast

NVST Sales Forecast

NVST Stock Forecast FAQ

Detailed List of Analyst Forecasts